Marshall University Joan C. Edwards School of Medicine is initiating a new clinical trial to evaluate the efficacy and safety of using biologic augmentation during anterior cruciate ligament, or ACL reconstructive surgery.
This minimally invasive technique uses a mixture of bone marrow concentrate, autograft bone and demineralized bone matrix to fill the tunnels within the knee joint during traditional ACL reconstruction. This technique also utilizes an innovative concept of internal brace reinforcement to improve the stability of the healing ACL.
The Principal Investigator
Chad D. Lavender, MD, board-certified orthopedic surgeon at Marshall Health and assistant professor in the department of orthopedic surgery at Marshall’s School of Medicine, was the lead on the development of the new technique known as “fertilized ACL.” Dr. Lavender noted, “Our goal is to identify and quantify possible improvements in pain, failure rates and clinical outcomes from our enhanced ACL technique. We will closely follow return to play outcomes and will be obtaining advanced imaging to show healing of our reconstructions and surrounding issues.”
Marshall is now recruiting 100 patients for the study. Patients pass the inclusion criteria will be randomly selected into two groups—one using biologic augmentation and one using traditional ACL reconstruction. Half will undergo surgery with the studied technique. Participants will attend regularly scheduled study visits with Marshall Health physicians for ongoing assessment. Marshall Health will contribute to costs.
Lead Research/Investigator Contact
Call to Action: If you believe you can meet the inclusion criteria, contact the Marshall Health team in Teays Valley at 304-691-6710.